ANDREW WANG: Open Payments
NPI 1417184144 · WEST ROXBURY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,776 in 191 payments from 17 companies in 2025. Trend: 2023 $32,208 · 2024 $30,859 · 2025 $30,776
Consulting: $12,825Speaker / faculty: $10,878Food & beverage: $5,731Travel & lodging: $1,275Education: $67
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $11,176 |
| Novartis Pharmaceuticals Corporation | 19 | $8,557 |
| PFIZER INC. | 8 | $4,963 |
| UCB, Inc. | 34 | $2,924 |
| ABBVIE INC. | 29 | $990 |
| E.R. Squibb & Sons, L.L.C. | 13 | $352 |
| GENZYME CORPORATION | 6 | $343 |
| Janssen Biotech, Inc. | 9 | $253 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $234 |
| Galderma Laboratories, L.P. | 12 | $209 |
Products named: OTEZLA, CIBINQO, Bimzelx, COSENTYX, RINVOQ, Sotyktu, DUPIXENT, TREMFYA.
Industry payments across MA — which companies pay providers there.
